𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is Minimal Residual Disease Monitoring Clinically Relevant in Adults with Acute Myelogenous Leukemia?

✍ Scribed by Carlson, Karen-Sue B.; Guzman, Monica L.


Book ID
120265063
Publisher
Current Science Inc.
Year
2013
Tongue
English
Weight
165 KB
Volume
8
Category
Article
ISSN
1558-8211

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Monitoring of minimal residual disease i
✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo